关于问题期刊Medical Hypothesis的投票结果

2010-06-18 MedSci原创 MedSci原创

作者:孙尉翔 前段时间,Elsevier平台下的期刊Medical Hypothesis引起了很大的风波。该期刊不执行同行评议,并且公开其初衷是发表: radical, speculative, and non-mainstream scientific ideas 直到该期刊登出一篇关于AIDS并非HIV导致的hypothesis,学术界的不满情绪

作者:孙尉翔

    前段时间,Elsevier平台下的期刊Medical Hypothesis引起了很大的风波。该期刊不执行同行评议,并且公开其初衷是发表:

radical, speculative, and non-mainstream scientific ideas

直到该期刊登出一篇关于AIDS并非HIV导致的hypothesis,学术界的不满情绪就爆发了。Elsevier要求该期刊主编马上建立同行评议机制,否则必须撤刊。Elsevier旗下王牌医学期刊The Lancet也刊发社论批评Medical Hypothesis。但也有不少人认为hypothesis是科学进步的创新之源,乐见该刊的延续。我曾经就此写过一篇文章Science针对此展开的网上投票近日公布了结果。有 50.4%支持票、38.2%反对票,剩下的是不确定票,总票数为1368。我也投了票,是支持票。反对意见中比较主流的反倒不是说没有同行评议就不行,而是担心该刊的内容被媒体和公众误认为证据确凿的科学结论来宣传和对待——他们认为哪怕该期刊作出清楚的声明,媒体和公众总之还是会误解。

Medical Hypothesis和我国民科的不同之处在于,该刊以大标题承认自己的内容仅仅是hypothesis,并且不乐意媒体将其内容作为 conclusion去宣传;而我国的民科往往相反。该刊没有同行评议,之所以仍然可以安全存在,恰恰它的读者设置于同行并不缺位的学术圈内部,而不是充满非同行的大众媒体。它之前所惹的麻烦就证明了这一点:一篇AIDS不由HIV导致的hypothesis首先是在学术圈内部引起争议,而不是先到社会公众之间忽悠一圈再等专家来辟谣,说明它是学术圈内部,同行之间的事情。期刊没有设置小同行评议,却不拒置身于大同行评议之中。

在保证这一点下,科学家们并不反对胡思乱想,反而很喜欢这么做。我看,做科研的最大乐趣就是professor们下午茶时间互相吹牛。Medical Hypothesis只是把这种原本小圈子内的吹牛内容公开给大圈子,过半数人支持当然是可以预见的,不支持的人多数也是担心媒体误读,并不是害怕hypothesis本身——这从投票结果下面的评论区里就能看出来。

本文引用地址: http://www.sciencenet.cn/m/user_content.aspx?id=333565

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1858548, encodeId=d953185854822, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon Dec 20 09:31:00 CST 2010, time=2010-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449, encodeId=a5f4144930, content=有意思,继续关注一下。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wuhantiyuan, createdTime=Mon Jul 12 11:20:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533535, encodeId=12b0153353527, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588134, encodeId=bafa158813457, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605530, encodeId=fd03160553075, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=)]
    2010-12-20 jeanqiuqiu
  2. [GetPortalCommentsPageByObjectIdResponse(id=1858548, encodeId=d953185854822, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon Dec 20 09:31:00 CST 2010, time=2010-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449, encodeId=a5f4144930, content=有意思,继续关注一下。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wuhantiyuan, createdTime=Mon Jul 12 11:20:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533535, encodeId=12b0153353527, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588134, encodeId=bafa158813457, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605530, encodeId=fd03160553075, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=)]
    2010-07-12 wuhantiyuan

    有意思,继续关注一下。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1858548, encodeId=d953185854822, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon Dec 20 09:31:00 CST 2010, time=2010-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449, encodeId=a5f4144930, content=有意思,继续关注一下。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wuhantiyuan, createdTime=Mon Jul 12 11:20:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533535, encodeId=12b0153353527, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588134, encodeId=bafa158813457, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605530, encodeId=fd03160553075, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=)]
    2010-06-20 海豹
  4. [GetPortalCommentsPageByObjectIdResponse(id=1858548, encodeId=d953185854822, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon Dec 20 09:31:00 CST 2010, time=2010-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449, encodeId=a5f4144930, content=有意思,继续关注一下。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wuhantiyuan, createdTime=Mon Jul 12 11:20:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533535, encodeId=12b0153353527, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588134, encodeId=bafa158813457, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605530, encodeId=fd03160553075, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=)]
    2010-06-20 skhzy
  5. [GetPortalCommentsPageByObjectIdResponse(id=1858548, encodeId=d953185854822, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Mon Dec 20 09:31:00 CST 2010, time=2010-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449, encodeId=a5f4144930, content=有意思,继续关注一下。, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wuhantiyuan, createdTime=Mon Jul 12 11:20:00 CST 2010, time=2010-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533535, encodeId=12b0153353527, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588134, encodeId=bafa158813457, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605530, encodeId=fd03160553075, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 20 06:31:00 CST 2010, time=2010-06-20, status=1, ipAttribution=)]

相关资讯

MedSci应邀参加2010年广州-东莞首届国际小型猪论坛

2010年1月8-10日,由广东省科学技术厅主办的“2010年广州-东莞首届国际小型猪论坛”于东莞落下帷幕。此次论坛吸引到近400名国内外相关人士参加,并就相关问题进行了深入交流和讨论。 小型猪和人的器官系统不仅在形态上相似而且生理学功能也基本相同,因此在生物医学中,小型猪越来

英国杂志称官僚干预学术推动中国科研造假

MedSci编者按:谨遵科学道德和科研严谨精神,呼吁中国的临床科研工作者能将一流的成果发表到国际杂志上去。但是呼吁作者杜绝任何形式的造假,作弊,一稿多投等行为。MedSci在评估过程中,经常收到已发表的文章,作者想再次发表,MedSci对此一律拒绝。另外,也经常收到一些实验数据明显不符合常规,我们也要求作者补充实验或给出合理解释,因为这些不符合常规,如果确实是严谨实验结果的话,那是令人振奋的。如果

MedSci新增全国免费科研服务热线: 400-6408-988

为了方便广大客户与我们联系,我们不仅开通了多门电话,在线留言,在线客服,但是仍然有不少用户无法打进电话(电话可能处于占线之中)。因此,又特开设400全国免费电话,无论是手机,还是固话,均可以拨打:400-6408-988,如果是我们的办事处或分公司地方,电话会直接转接至我们的当地销售顾问,更方便地为您提供服务和咨询。 M

MedSci参加2010干细胞技术与应用讲座

    为期两天的2010干细胞技术与应用讲座于4月16日圆满落下帷幕,共有五百余名来自于高校科研院所、企事业单位、医院人员参加了此次盛会。时玉舫、肖磊、牛新乐、朱剑虹、刘伟、周琪、赖良学、邓宏魁、裴端卿、杨黄恬、高翔、张岩、金颖等国内干细胞领域顶级专家出席了此次会议并做精彩的演讲,众专家结合自己的研究领域,客观上多角度、全方位的展示国内干细胞研究的最新进展。生物谷旗

“期刊投稿智能支持系统(JSAS)”测试版开通

文章投稿选择什么杂志,一直是大家的难题,许多用户,只知道自己熟悉的十来种杂志,投稿的选择面非常窄。应广大用户的要求,MedSci技术人员,日夜攻关,继影响因子,投稿建议和杂志主页系统(http://www.medsci.cn/sci/)上线后,再次上线一个重大项目:期刊投稿智能支持系统(Journal selection-assisted system, JS

学术科研网上信息快速导航

MedSci团队始终致力于从事临床和科研教育、培训活动。我们愿意与我们的客户一起发展,全方位提升客户在SCI论文和学术研究方面的知识与水平,让客户真正掌握SCI论文,乃至学术研究的每一个环节和要素。 文献与数据库 综合数据库    中国知网 ScienceDirect    万方数据资源系统 SpringerLink    中国科研机构数据